Interpretation of pulmonary function test: Issues and controversies

Clinical Reviews in Allergy and Immunology

Volumn 37, Issue 3, 2009, Pages 173-180

  Berry, Cristine E ^a   Wise, Robert A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Lung volume measurements; Pulmonary diffusing capacity; Respiratory function tests; Spirometry

Indexed keywords

DISEASE SEVERITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FLOW VOLUME CURVE; LUNG FUNCTION TEST; NORMAL VALUE; OBSTRUCTIVE AIRWAY DISEASE; RACE DIFFERENCE; RESTRICTIVE LUNG DISEASE; REVIEW; SPIROMETRY; STANDARD;

ALGORITHMS; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG; LUNG DISEASES, OBSTRUCTIVE; REFERENCE STANDARDS; REFERENCE VALUES; REGIONAL BLOOD FLOW; RESPIRATORY FUNCTION TESTS;

EID: 71949093477     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8123-4     Document Type: Review

References (41)

1. R Pellegrino G Viege V Brusasco RO Crapo F Burgos R Casaburi A Coates CPM van der Grinten P Gustafsson J Hankinson R Jensen DC Johnson N Macintyre R McKay MR Miller D Navajas OF Pedersen J Wanger 2005 Interpretative strategies for lung function tests Eur Respir J 26 948 968 10.1183/09031936.05.00035205 1:STN:280:DC%2BD2MrosFSgtQ%3D%3D 16264058 (Pubitemid 41632054)
2. MC McCormack D Shade RA Wise 2007 Spirometer calibration checks: is 3.5% good enough? Chest 131 1486 1493 10.1378/chest.06-1522 17494798 (Pubitemid 46762357)
3. RO Crapo 2004 The role of reference values in interpreting lung function tests Eur Respir J 24 341 342 10.1183/09031936.04.00063804 1:STN:280: DC%2BD2cvltVSksQ%3D%3D 15358686 (Pubitemid 39232250)
4. J Collen D Greenburg A Holley CS King O Hnatiuk 2008 Discordance in spirometric interpretations using three commonly used reference equations vs national health and nutrition examination study III Chest 134 1009 1016 10.1378/chest.08-0614 18988777
5. RI Harik-Khan JL Fleg DC Muller RA Wise 2001 The effect of anthropometric and socioeconomic factors on the racial difference in lung function Am J Respir Crit Care Med 164 1647 1654 1:STN:280:DC%2BD38zgsVeqsA%3D%3D 11719304
6. Disability Evaluation Under Social Security; Respiratory System-Adult; Category of Impairments-Respiratory System. Accessed online on Feb 25, 2009 at http://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm
7. JP Zheng NS Zhong 2002 Normative values of pulmonary function testing in Chinese adults Chinese Med J 2002 50 54
8. MS Ip FW Ko AC Lau WC Yu KS Tang K Choo MM Chan-Yeung Hong Kong Thoracic Society American College of Chest Physicians (Hong Kong and Macau Chapter) 2006 Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization Chest 129 384 392 10.1378/chest.129.2.384 16478856 (Pubitemid 43289859)
9. AJ Ghio RO Crapo CG Elliott 1990 Reference equations used to predict pulmonary function. Survey at institutions with respiratory disease training programs in the United States and Canada Chest 97 400 403 10.1378/chest.97.2.400 1:STN:280:DyaK3c7isF2ntQ%3D%3D 2298065
10. Permutt S, Menkes HA (1979) Spirometry: Analysis of Forced Expiration Within the Time Domain. In: Macklem PT, Permutt S (eds) The lung in the transition between health and disease. M. Dekker, New York, pp 113-152
11. HE Fessler S Permutt 1998 Lung volume reduction surgery and airflow limitation Am J Respir Crit Care Med 157 715 722 1:STN:280:DyaK1c7ns1Omug%3D%3D 9517581
12. BR Celli W Macnee Committee members 2004 Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 932 946 10.1183/09031936.04.00014304 1:STN:280: DC%2BD2czhsleisQ%3D%3D 15219010
13. DM Mannino AS Buist TL Petty PL Enright SC Redd 2003 Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study Thorax 58 388 393 10.1136/thorax.58.5.388 1:STN:280:DC%2BD3s3jslyjsg%3D%3D 12728157 (Pubitemid 36560940)
14. NR Anthonisen MA Skeans RA Wise J Manfreda RE Kanner JE Connett Lung Health Study Research Group 2005 The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial Ann Intern Med 142 233 239 15710956
15. FJ Martinez MK Han AC Andrei R Wise S Murray JL Curtis A Sternberg G Criner SE Gay J Reilly B Make AL Ries F Sciurba G Weinmann Z Mosenifar M DeCamp AP Fishman BR Celli 2008 Longitudinal change in the BODE index predicts mortality in severe emphysema Am J Respir Crit Care Med 178 491 499 10.1164/rccm.200709-1383OC 18535255
16. DP Tashkin B Celli S Senn D Burkhart S Kesten S Menjoge M Decramer 2008 UPLIFT Study Investigators A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 543 554 10.1056/NEJMoa0805800
17. PM Calverley JA Anderson B Celli GT Ferguson C Jenkins PW Jones JC Yates J Vestbo TORCH investigators 2007 Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 775 789 10.1056/NEJMoa063070 1:CAS:528:DC%2BD2sXhvFKltL0%3D 17314337 (Pubitemid 46294610)
18. B Burrows RJ Knudson AE Camilli SK Lyle MD Lebowitz 1987 The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry Am Rev Respir Dis 135 788 793 1:STN:280:DyaL2s7ot1Kgtw%3D%3D 3565926
19. DE O'Donnell M Lam KA Webb 1999 Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 542 549 10430726
20. Wise RA (2004) The epidemiology of chronic obstructive pulmonary disease. In: Lung Volume Reduction Surgery for Emphysema, Fessler HE, JJ Reilly, Jr., and DJ Sugarbaker (eds). Lung Biology in Health and Disease Monographs. Marcel Dekker, Vol 184, pp 1-22
21. KF Rabe S Hurd A Anzueto PJ Barnes SA Buist P Calverley Y Fukushi C Jenkins R Rodriguez-Roisin C van Weel J Zielinski 2007 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease-GOLD executive summary Am J Respir Crit Care Med 176 532 555 10.1164/rccm.200703-456SO 17507545 (Pubitemid 47403272)
22. Wise RA and S Permutt. Evaluation of Lung Function: Determination of Pulmonary Impairment. DH Simmons (ed). In: Current Pulmonology Vol. 6, pp. 307-327, 1985, John Wiley & Sons, Inc. NY
23. DE O'Donnell M Lam KA Webb 1999 Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 542 549 10430726
24. C Casanova C Cote JP de Torres A Aguirre-Jaime JM Marin V Pinto-Plata BR Celli 2005 Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 171 591 597 10.1164/rccm.200407-867OC 15591470 (Pubitemid 40365414)
25. PM Calverley PS Burge S Spencer JA Anderson PW Jones 2003 Bronchodilator reversibility testing in chronic obstructive pulmonary disease Thorax 58 659 664 10.1136/thorax.58.8.659 1:STN:280:DC%2BD3szltlyqsA%3D%3D 12885978 (Pubitemid 36976273)
26. SD Aaron RE Dales P Cardinal 1999 How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 115 869 873 10.1378/chest.115.3.869 1:STN:280:DyaK1M7otF2qtQ%3D%3D 10084506 (Pubitemid 29129975)
27. RE Hyatt CT Cowl JA Bioraker PD Scanlon 2009 Conditions associated with an abnormal nonspecific pattern of pulmonary function tests Chest 135 419 424 10.1378/chest.08-1235 18812444
28. MB Drummond PF Schwartz WT Duggan JG Teeter RJ Riese RC Ahrens RO Crapo RD England NR Macintyre RL Jensen RA Wise 2008 Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease Am J Respir Crit Care Med 178 225 232 10.1164/rccm.200801-090OC 18467511
29. BR Thompson DP Johns M Bailey J Raven EH Walters MJ Abramson 2008 Prediction equations for single breath diffusing capacity (Tlco) in a middle aged Caucasian population Thorax 63 889 893 10.1136/thx.2007.091959 1:STN:280:DC%2BD1cnivVCrtQ%3D%3D 18390632
30. M Peters-Golden RA Wise MC Hochberg MB Stevens FM Wigley 1984 Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis Am J Med 77 1027 1034 10.1016/0002-9343(84)90183-9 1:STN:280:DyaL2M%2FmvFGhsA%3D%3D 6507456 (Pubitemid 15221764)
31. PI Latsi RM du Bois AG Nicholson TV Colby D Bisirtzoglou A Nikolakopoulou S Veeraraghavan DM Hansell AU Wells 2003 Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends Am J Respir Crit Care Med 168 531 537 10.1164/rccm.200210-1245OC 12791580 (Pubitemid 37088594)
32. MK Ferguson WT Vigneswaran 2008 Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease Ann Thorac Surg 85 1158 1164 10.1016/j.athoracsur.2007.12.071 18355489
33. GR Owens RM Rogers BE Pennock D Levin 1984 The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease N Engl J Med 310 1218 1221 1:STN:280:DyaL2c7mvVSkuw%3D%3D 6709028
34. AL Ries JT Farrow JL Clausen 1988 Pulmonary function tests cannot predict exercise-induced hypoxemia in chronic obstructive pulmonary disease Chest 93 454 459 10.1378/chest.93.3.454 1:STN:280:DyaL1c7js1KmsA%3D%3D 3125012
35. DC Johnson 2000 Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume Respir Med 94 28 37 10.1053/rmed.1999.0740 1:STN:280: DC%2BD3c7ns12gtA%3D%3D 10714476 (Pubitemid 30113847)
36. JM Hughes NB Pride 2001 In defence of the carbon monoxide transfer coefficient Kco (TL/VA) Eur Respir J 17 168 174 10.1183/09031936.01.17201680 1:STN:280:DC%2BD3M3jvVCgtA%3D%3D 11334115 (Pubitemid 32600573)
37. G Saydain KC Beck PA Decker CT Cowl PD Scanlon 2004 Clinical significance of elevated diffusing capacity Chest 125 446 452 10.1378/chest.125.2.446 14769723 (Pubitemid 38223622)
38. WH Ettinger RA Wise MB Stevens FM Wigley 1983 Absence of positional change in pulmonary diffusing capacity in systemic sclerosis Am J Med 75 305 312 10.1016/0002-9343(83)91209-3 1:STN:280:DyaL3s3otVSlsw%3D%3D 6881183
39. NB Pride S Permutt RL Riley B Bromberger-Barnea 1967 Determinants of maximal expiratory flow from the lungs J Appl Physiol 23 646 662 1:STN:280:DyaF1c%2FlsVOnsA%3D%3D 6061379
40. EF Haponik AM Munster RA Wise PL Smith DA Meyers EJ Britt ER Bleecker 1984 Upper airway function in burn patients. Correlation of flow-volume curves and nasopharyngoscopy Am Rev Respir Dis 129 251 257 1:STN:280: DyaL2c7is1amug%3D%3D 6696326
41. EF Haponik ER Bleecker RP Allen PL Smith J Kaplan 1981 Abnormal inspiratory flow-volume curves in patients with sleep-disordered breathing Am Rev Respir Dis 124 571 574 1:STN:280:DyaL38%2Fms1ertw%3D%3D 7305112